(MRTX) Alert: Did You Lose Money on Your Mirati Therapeutics Investment? Contact Johnson Fistel Regarding Investigation
SAN DIEGO, Nov. 2, 2021 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Mirati Therapeutics, Inc. (NASDAQ: MRTX) for violations of federal securities laws.
On November 1, 2021, Mirati, in an SEC filing, disclosed that certain executives would no longer be serving in their positions. In the filing, the Company stated, "On October 28, 2021, it was determined that Daniel R. Faga would cease serving as the Executive Vice President, Chief Operating Officer and principal financial officer of Mirati Therapeutics, Inc. (the "Company") and that Joseph Leveque would cease serving as the Company's Executive Vice President and Chief Medical Officer, effective as of November 1, 2021."
Following this news, Mirati stock fell 13.57% on November 1, 2021.
If you have information that could assist in this investigation, including past employees and others, or if you are a Mirati shareholder and are interested in learning more about the investigation, please contact Jim Baker ([email protected]) at 619-814-4471. If emailing, please include a phone number.
Additionally, you can [Click here to join this action]. There is no cost or obligation to you.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
[email protected]
[Click here to join this action]
SOURCE Johnson Fistel, LLP
![](https://rt.prnewswire.com/rt.gif?NewsItemId=PH60809&Transmission_Id=202111020847PR_NEWS_USPR_____PH60809&DateId=20211102)
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
![icon3](/content/dam/newsfeatured/icon3.png)
Newsrooms &
Influencers
![icon1](/content/dam/newsfeatured/icon1.png)
Digital Media
Outlets
![icon2](/content/dam/newsfeatured/icon2.png)
Journalists
Opted In
Share this article